Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMJ Oncology|January 31, 2025
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapyRebecca C Obeng, Tahseen H Nasti, Kylee Martens, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2020
Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor ActivityDaniel A Pomeranz Krummel, Tahseen H Nasti, Milota Kaluzova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2023
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 BlockadeAnnapaola Mariniello, Tahseen H Nasti, Daniel Y Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2026
Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infectionMasao Hashimoto, Tahseen H Nasti, Hyun-Tak Jin, et al.
Research Square|February 27, 2024
Early generation of a precursor CD8 T cell that can adapt to acute or chronic viral infectionDaniel T McManus, Rajesh M Valanparambil, Christopher B Medina, et al.
NPJ Vaccines|November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancerRajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.
Nature|January 8, 2025
An early precursor CD8+ T cell that adapts to acute or chronic viral infectionDaniel T McManus, Rajesh M Valanparambil, Christopher B Medina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron VariantRajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman, et al.
Pageof 5